RBC Capital keeps an Outperform rating and $41 price target on Keurig Dr Pepper (KDP) ahead of its Q3 results. The firm expects the company to post a “solid” quarter with sequential organic growth improvement driven by outperformance in coffee and slight pressure on U.S. Refreshment Beverages, the analyst tells investors in a research note. RBC adds that tracked channel data shows notable improvement in Keurig Dr Pepper coffee pod volumes and generally stable beverage trends.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- KDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Keurig Dr Pepper price target raised to $41 from $37 at Barclays
- Keurig Dr Pepper price target raised to $40 from $35 at TD Cowen
- Microsoft downgraded, Pinterest initiated: Wall Street’s top analyst calls
- Keurig Dr Pepper price target raised to $37 from $36 at Deutsche Bank